Polymeric IgA1 from Patients with IgA Nephropathy Upregulates Transforming Growth Factor-β Synthesis and Signal Transduction in Human Mesangial Cells via the Renin-Angiotensin System

Journal of the American Society of Nephrology

Volumn 14, Issue 12, 2003, Pages 3127-3137

  Lai, Kar Neng ^a   Tang, Sydney C W ^a   Guh, Jinn Yuh ^b   Chuang, Tsai Der ^b   Lam, Man Fai ^a   Chan, Loretta Y Y ^a   Tsang, Anita W L ^a   Leung, Joseph C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; LOSARTAN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY DISEASE; KIDNEY FIBROSIS; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SYNTHESIS; UPREGULATION;

EID: 0344667757     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000095639.56212.BF     Document Type: Article

References (47)

1. Schena FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89: 209-215, 1990
2. + cells from patients with IgA nephropathy. Kidney Int 46: 862-868, 1994
3. Sakai H, Nomoto Y, Arimori S, Komori K, Inouye H, Tsuji K: Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy. Am J Clin Pathol 72: 452-456, 1979
4. Schena FP, Mastrolitti G, Fracasso AR, Pastore A, Ladisa N: Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephropathy. Clin Nephrol 26: 163-168, 1986
5. Lai KN, Lai FM, Chui SH, Chan YM, Tsao GS, Leung KN, Lam CW: Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy. Clin Nephrol 28: 281-287, 1986
6. Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, van Es LA: Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 26: 760-766, 1984
7. Lai KN, Chui SH, Lewis WH, Poon AS, Lam CW: Charge distribution of IgA-λ in IgA nephropathy. Nephron 66: 38-44, 1994
8. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J: Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 10: 1763-1771, 1999
9. Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, Ghiggeri GM, Cooper K, Amoroso A, Viola BF, Battini G, Caridi G, Canova C, Farhi A, Subramanian V, Nelson-Williams C, Woodford S, Julian BA, Wyatt RJ, Lifton RP: IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26: 354-357, 2000
10. Lai KN, Leung JCK: Heat-aggregated IgA prepared from patients with IgA nephropathy increases calcium mobilization and superoxide production of human neutrophils in vitro. Nephron 64: 129-135, 1993
11. Lai KN, Leung JCK, Li PKT: Heat-aggregated IgA prepared from patients with IgA nephropathy increases priming of human neutrophils to produce inositol triphosphate following FMLP stimulation in vitro. Nephron 69: 1-8, 1995
12. Ketteler M, Noble NA, Border WA: Increased expression of transforming growth factor-β in renal disease. Curr Opin Nephrol Hypertens 3: 446-452, 1994
13. Bannister KM, Weaver A, Clarkson AR, Woodroffe AJ: Effect of angiotensin-converting enzyme and calcium channel inhibition on progressive nephropathy. Contrib Nephrol 111: 184-192, 1995
14. Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM: Coadministration of losartan and enalapril exerts additive anti-proteinuric effect in IgA nephropathy. Am J Kidney Dis 38: 18-25, 2001
15. Leung JCK, Tang SCW, Lam MF, Chan TM, Lai KN: Charge dependent binding of polymeric IgA1 to human mesangial cell in IgA nephropathy. Kidney Int 59: 277-285, 2001
16. Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J: The nephrotic range proteinuria: A good predictive index of progressive disease in IgA nephropathy? Q J Med 57: 677-688, 1985
17. Lai KN, Li FK, Lan HY, Tang S, Tsang A, Chan TM, Leung JCK: Expression of aquaporin 1 in human mesothelial peritoneal cells and its upregulation by glucose in vitro. J Am Soc Nephrol 12: 1036-1045, 2001
18. Leung JCK, Tsang AW, Chan TM, Lai KN: Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 11: 241-249, 2000
19. Lai KN, Lai KB, Lam CWK, Chan TM, Li FK, Leung JCK: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 35: 644-652, 2000
20. Volland H, Pradelles P, Ronco P, Azizi M, Simon D, Creminon C, Grassi J: A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J Immunol Methods 228: 37-47, 1999
21. Huang JS, Guh JY, Hung WC, Yang ML, Lai YH, Chen HC, Chuang LY: Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Biochem J 342: 231-238, 1999
22. Jonk LJC, Itoh S, Heldin CH, Dijke PT, Kruijer W: Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273: 21145-21152, 1998
23. Gomez-Guerrero C, Duque N, Egido J: Stimulation of Fcα receptors induces tyrosine phosphorylation of phospholipase C-γ, phosphatidylinositol phosphate hydrolysis, and calcium mobilization in rat and human mesangial cells. J Immunol 156: 4369-4376, 1996
24. Duque N, Gomez-Guerrero C, Egido J: Interaction of IgA with Fcα receptors of human mesangial cells activates transcription factor nuclear factor-κB and induces expression and synthesis of MCP-1, IL-8, and IFN-inducible protein 10. J Immunol 159: 3474-3482, 1997
25. Diven SC, Caflisch CR, Hammond DK, Weigel PH, Oka JA, Goldblum RM: IgA induced activation of human mesangial cells: Independent of FcαR1 (CD89). Kidney Int 54: 837-847, 1998
26. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, van den Wall Bake AW, van Es LA, Daha MR: Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 46: 512-519, 1994
27. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-α and IL-6, and proliferation. J Immunol 153: 5247-5255, 1994
28. Wada T, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Naito T, Kobayashi K, Mukaida N, Matsushima K: Detection of urinary interleukin 8 in glomerular diseases. Kidney Int 46: 455-460, 1994
29. Peruzzi L, Amore A, Cirina P, Trusolina L, Basso G, Ricotti E, Emancipator SN, Marchisio PC, Coppo R: Integrin expression and IgA nephropathy: In vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int 58: 2331-2340, 2000
30. GISEN (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863, 1997
31. Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int 58[Suppl 77]: S93-S98, 2000
32. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
33. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-β regulates tubular epithelial-myofibroblast trans-differentiation in vitro. Kidney Int 56:1455-1467, 1999
34. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY: Smad 7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad 2 activation. J Am Soc Nephrol 13: 1464-1472, 2002
35. Lai KN, Leung JCK, Lai KB, To WY, Yeung VTF, Lai FM: Gene expression of the renin-angiotensin system in human kidney. J Hypertens 16: 91-102, 1998
36. Galla JH: Molecular genetics in IgA nephropathy. Nephron 88: 107-112, 2001
37. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28: 666-671, 1985
38. Lai KN, To WY, Li PK, Leung JC: Increased binding of polymeric λ-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int 49: 839-845, 1996
39. Duchin KL, McKinstry DN, Cohen AI, Migdalof BH: Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases. Clin Pharmacokinet 14: 241-259, 1988
40. Munafo A, Christen Y, Nussberger J, Shum LY, Borland M, Lee RJ, Waeber B, Biollaz J, Brunner HR: Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clin Pharmacol Ther 51: 513-521, 1992
41. Li K, Tan L, Zhou JA: HPLC determination of captopril in human plasma and its pharmacokinetic study. Biomed Chromatogr 10: 237-239, 1996
42. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD: Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP 3174 in human. Clin Pharmacol Ther 58: 641-649, 1995
43. Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R: Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 33: 851-856, 1999
44. Roccatello D, Mengozzi G, Gigliola G, Rossi D, Mosso R, Cacace G, Polloni R, Cesano G, Picciotto G, Paradisi L, Bancale E, Piccoli G, Sena LM: Effect of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy. Nephrol Dial Transplant 15: 988-993, 2000
45. Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN: Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18: 36-45, 2003
46. Massague J, Chen YG: Controlling TGF-β signalling. Genes Dev 14:627-644, 2000
47. Kanamaru Y, Nakao A, Mamura M, Suzuki Y, Shirato I, Okumura K, Tomino Y, Ra C: Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 166: 2818-2823, 2001